Advertisement.

SNRE Projected Dividend Yield

Sorrento Therapeutics Inc ( NASDAQ : SNRE )

Sorrento Therapeutics, together with its subsidiaries, is a clinical stage and commercial biopharmaceutical company developing a portfolio of treatments for three primary therapeutic areas: cancer, infectious disease and pain. Co. is focused on transforming science into Saving Life Medicines™ by developing product programs into focused commercial entities, like Scilex Holding Company (Scilex Holding). Co.'s proprietary fully human G-MAB™ antibody library and ACEA small molecule library are the engines driving a pipeline of solutions for cancer. Scilex Holding's main product, ZTlido®, has been launched as a prescription lidocaine topical product.

20 YEAR PERFORMANCE RESULTS

SNRE Dividend History Detail
SNRE Dividend News
SNRE Competitors News

# of Shares: 0

Closing Price: 45.61

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000